HLX-318

N/A

Report date: 2025/09/15 14:47:56

Base Information

Drug NameHLX-318
Drug Alias NameHLX-318HLX318
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionB-cell activating factor receptor modulatorsTumor necrosis factor receptor superfamily member 13B modulatorsB-cell maturation protein modulators
TargetsB-cell activating factor receptorTumor necrosis factor receptor superfamily member 13BB-cell maturation protein
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Henlius Biotech Inc
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Henlius Biotech Inc
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A